<SEC-DOCUMENT>0001477037-21-000002-index.html : 20210304
<SEC-HEADER>0001477037-21-000002.hdr.sgml : 20210304
<ACCEPTANCE-DATETIME>20210304190243
ACCESSION NUMBER:		0001477037-21-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201218
FILED AS OF DATE:		20210304
DATE AS OF CHANGE:		20210304

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Do Cuong V
		CENTRAL INDEX KEY:			0001477037

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39015
		FILM NUMBER:		21715929

	MAIL ADDRESS:	
		STREET 1:		C/O BIOVIE
		STREET 2:		2120 COLORADO AVENUE, SUITE 230
		CITY:			SANTA MONICA
		STATE:			CA
		ZIP:			90404

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOVIE INC.
		CENTRAL INDEX KEY:			0001580149
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462510769
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		2120 COLORADO AVE.
		STREET 2:		SUITE 230
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90404
		BUSINESS PHONE:		310-444-4300

	MAIL ADDRESS:	
		STREET 1:		2120 COLORADO AVE.
		STREET 2:		SUITE 230
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOANTIBIOTICS, INC.
		DATE OF NAME CHANGE:	20130625
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>